# Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine

> **NCT01475539** · PHASE4 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 456 (actual)

## Conditions studied

- Polio
- Poliomyelitis

## Interventions

- **BIOLOGICAL:** Injectable inactivated types 1, 2 and 3 poliovirus + Live oral Polio
- **BIOLOGICAL:** Injectable inactivated types 1, 2 and 3 poliovirus + Live oral Polio
- **BIOLOGICAL:** Live oral poliovirus type 1, 2 and 3

## Key facts

- **NCT ID:** NCT01475539
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2013-05
- **Final completion:** 2013-11
- **Target enrollment:** 456 (ACTUAL)
- **Last updated:** 2015-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01475539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01475539, "Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT01475539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*